OBJECTIVE: To evaluate the clinical characteristics and outcome of non-invasive ventilation (NIV) in an epidemiological based series of amyotrophic lateral sclerosis (ALS) patients. METHODS: The study was performed using data from the Piemonte and Valle d'Aosta Register for ALS, a prospective epidemiological register enrolling all ALS incident cases in two Italian regions. RESULTS: Among the 1260 patients incident in the period 1995-2004, 259 (20.6%) underwent NIV. Young male patients and subjects attending the tertiary ALS centres were more likely to undergo NIV. There was a progressive significant increase in the use of NIV during the study but was limited to patients attending the ALS tertiary centres. Median survival after NIV was 289 days (95% CI 255 to 333). CONCLUSIONS: In an epidemiological setting, NIV represents an increasingly utilised option for the treatment of respiratory disturbances in ALS and has favourable effects on survival, in particular among patients followed by tertiary ALS centres. Sociocultural factors, such as age, gender and marital status, strongly influence the probability of undergoing NIV. Efforts should be made to remove these obstacles in order to spread the use of NIV in all ALS patients with respiratory failure.
OBJECTIVE: To evaluate the clinical characteristics and outcome of non-invasive ventilation (NIV) in an epidemiological based series of amyotrophic lateral sclerosis (ALS) patients. METHODS: The study was performed using data from the Piemonte and Valle d'Aosta Register for ALS, a prospective epidemiological register enrolling all ALS incident cases in two Italian regions. RESULTS: Among the 1260 patients incident in the period 1995-2004, 259 (20.6%) underwent NIV. Young male patients and subjects attending the tertiary ALS centres were more likely to undergo NIV. There was a progressive significant increase in the use of NIV during the study but was limited to patients attending the ALS tertiary centres. Median survival after NIV was 289 days (95% CI 255 to 333). CONCLUSIONS: In an epidemiological setting, NIV represents an increasingly utilised option for the treatment of respiratory disturbances in ALS and has favourable effects on survival, in particular among patients followed by tertiary ALS centres. Sociocultural factors, such as age, gender and marital status, strongly influence the probability of undergoing NIV. Efforts should be made to remove these obstacles in order to spread the use of NIV in all ALSpatients with respiratory failure.
Authors: Hiroshi Mitsumoto; Pam Factor-Litvak; Howard Andrews; Raymond R Goetz; Leslie Andrews; Judith G Rabkin; Martin McElhiney; Jeri Nieves; Regina M Santella; Jennifer Murphy; Jonathan Hupf; Jess Singleton; David Merle; Mary Kilty; Daragh Heitzman; Richard S Bedlack; Robert G Miller; Jonathan S Katz; Dallas Forshew; Richard J Barohn; Eric J Sorenson; Bjorn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Catherine Lomen-Hoerth; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Jeremy M Shefner; Jinsy A Andrews; Boguslawa A Koczon-Jaremko Journal: Amyotroph Lateral Scler Frontotemporal Degener Date: 2014-02-24 Impact factor: 4.092
Authors: L P Greenaway; N H Martin; V Lawrence; A Janssen; A Al-Chalabi; P N Leigh; L H Goldstein Journal: J Neurol Date: 2015-02-17 Impact factor: 4.849
Authors: Rosanna Cousins; Hikari Ando; Everard Thornton; Biswajit Chakrabarti; Robert Angus; Carolyn Young Journal: Health Psychol Behav Med Date: 2013-11-01
Authors: Tino Prell; Thomas M Ringer; Kara Wullenkord; Philipp Garrison; Anne Gunkel; Beatrice Stubendorff; Otto W Witte; Julian Grosskreutz Journal: J Neurol Neurosurg Psychiatry Date: 2016-03-24 Impact factor: 10.154
Authors: Giuseppe Fiorentino; Anna Annunziata; Anna Michela Gaeta; Maurizia Lanza; Antonio Esquinas Journal: Degener Neurol Neuromuscul Dis Date: 2018-09-04